AGE-RELATED MACULAR DEGENERATION (AMD)
Clinical trials for AGE-RELATED MACULAR DEGENERATION (AMD) explained in plain language.
Never miss a new study
Get alerted when new AGE-RELATED MACULAR DEGENERATION (AMD) trials appear
Sign up with your email to follow new studies for AGE-RELATED MACULAR DEGENERATION (AMD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a pill slow blind spots? new trial targets AMD-Related vision decline
Disease control Recruiting nowThis study tests whether taking a daily oral medication (dimethyl fumarate) for 12 months can slow the growth of geographic atrophy, a form of advanced age-related macular degeneration that causes blind spots. About 90 adults aged 55–85 with geographic atrophy will participate. T…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 01, 2026 14:33 UTC
-
New eye injection aims to halt blindness from dry AMD
Disease control Recruiting nowThis study tests an experimental eye injection called ONL1204 in 324 adults aged 55 and older with geographic atrophy, a form of dry age-related macular degeneration that causes blind spots. The goal is to see if the drug can slow the growth of damaged areas in the eye and preser…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Phase: PHASE2 • Sponsor: ONL Therapeutics • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
AI eye check in family clinics could save sight for thousands
Diagnosis Recruiting nowThis study tests whether using an AI tool (VeriSee) during regular checkups can help find two common eye diseases—diabetic retinopathy and age-related macular degeneration—earlier than standard exams. About 4,300 adults with diabetes or aged 50+ will be randomly assigned to eithe…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Apr 30, 2026 15:49 UTC
-
Veterans with vision loss pedal toward better sight in new study
Symptom relief Recruiting nowThis study tests whether a 6-month online spin cycling program can improve vision and daily function in 70 veterans aged 65-89 with intermediate age-related macular degeneration (AMD). AMD is a leading cause of vision loss, and there are few treatments. Participants will join gro…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Apr 30, 2026 15:48 UTC
-
Scientists hunt for protein fingerprints in common eye diseases
Knowledge-focused Recruiting nowThis study aims to find protein markers in blood and eye fluids that are linked to three major eye diseases: age-related macular degeneration, diabetic retinopathy, and retinal detachment. About 260 adults will provide samples during routine care. The goal is to improve understan…
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Phase: NA • Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:49 UTC
-
New eye Drug's early effects under the microscope in wet AMD study
Knowledge-focused Recruiting nowThis study is observing 50 people with wet age-related macular degeneration (AMD) to see how quickly a high-dose eye injection (Eylea 8mg) dries up fluid in the retina. Researchers will use special scans to measure fluid changes and vision improvements over the first two months. …
Matched conditions: AGE-RELATED MACULAR DEGENERATION (AMD)
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC